Metronomic gemcitabine suppresses tumour growth, improves perfusion, and reduces hypoxia in human pancreatic ductal adenocarcinoma.

In PaCa13 tumours, there was a trend towards increased CAF apoptosis after either gemcitabine regimen, but such increases did not reach statistical significance ( Figure 5B ).

also in 111,027 other papers